Paper14896
Tumorigenicity of human hematopoietic cell lines in athymic nude mice.
Nilsson K and 3 others. Int J Cancer, 1977. Cited by 221 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Papers, record 14896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14896
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Line | Major topic |
| Cell Transformation, Neoplastic | Major topic |
| Hematopoietic Stem Cell Transplantation | Major topic |
| Mice, Nude | Major topic |
| Animals | |
| Cells, Cultured | |
| Clone Cells | |
| Hematopoietic Stem Cells | |
| Herpesvirus 4, Human | |
| Humans | |
| Lymphocyte Transfusion | |
| Lymphocytes | |
| Mice | |
| Neoplasms, Experimental | |
| Sepharose | |
| Transplantation, Heterologous |
Source PubMed
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 221 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,626,690 | Epstein-Barr virus-infected tonsillar marginal zone B cells in vivo as a precursor for immunosuppression-related B-cell lymphoma. | J Virol | 2025 | https://conductscience.org/library/papers/40626690 | PubMed |
| 39,068,166 | Glutathione overproduction mediates lymphoma initiating cells survival and has a sex-dependent effect on lymphomagenesis. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/39068166 | PubMed |
| 29,880,607 | CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth. | Haematologica | 2018 | https://conductscience.org/library/papers/29880607 | PubMed |
| 25,594,060 | Up-regulation of anti-apoptotic genes confers resistance to the novel anti-leukaemic compound PEP005 in primary AML cells. | Oncoscience | 2014 | https://conductscience.org/library/papers/25594060 | PubMed |
| 25,162,594 | The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia. | PLoS One | 2014 | https://conductscience.org/library/papers/25162594 | PubMed |
| 23,526,987 | Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo. | PLoS One | 2013 | https://conductscience.org/library/papers/23526987 | PubMed |
| 22,475,873 | E2F4 plays a key role in Burkitt lymphoma tumorigenesis. | Leukemia | 2012 | https://conductscience.org/library/papers/22475873 | PubMed |
| 19,881,539 | Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. | Oncogene | 2010 | https://conductscience.org/library/papers/19881539 | PubMed |
| 19,406,837 | E2F1 expression is deregulated and plays an oncogenic role in sporadic Burkitt's lymphoma. | Cancer Res | 2009 | https://conductscience.org/library/papers/19406837 | PubMed |
| 15,759,039 | Animal models of acute myelogenous leukaemia - development, application and future perspectives. | Leukemia | 2005 | https://conductscience.org/library/papers/15759039 | PubMed |
| 12,808,131 | A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12808131 | PubMed |
| 8,709,292 | Characterization of tumor cell lines derived from murine gammaherpesvirus-68-infected mice. | J Virol | 1996 | https://conductscience.org/library/papers/8709292 | PubMed |
| 8,393,615 | Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-1a (CD11A). | Am J Pathol | 1993 | https://conductscience.org/library/papers/8393615 | PubMed |
| 7,807,183 | Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients. | J Neurooncol | 1994 | https://conductscience.org/library/papers/7807183 | PubMed |
| 7,276,066 | Hodgkin's disease: establishment and characterization of four in vitro cell lies. | J Cancer Res Clin Oncol | 1981 | https://conductscience.org/library/papers/7276066 | PubMed |
| 6,973,352 | Serial transplantation of a human T-cell acute lymphoblastic leukaemia line into nude mice. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6973352 | PubMed |
| 6,314,570 | Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes. | Springer Semin Immunopathol | 1982 | https://conductscience.org/library/papers/6314570 | PubMed |
| 6,311,121 | Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. | Ann Surg | 1983 | https://conductscience.org/library/papers/6311121 | PubMed |
| 6,310,019 | Epstein-Barr virus transformation of human pre-B cells. | J Exp Med | 1983 | https://conductscience.org/library/papers/6310019 | PubMed |
| 6,309,856 | Epstein-Barr virus (EBV), lymphocytes and transformation. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6309856 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14896
GET https://conductscience.org/api/papers/v1/14896/cited_by?page=2